5 High-density lipoprotein: A major risk factor for coronary atherosclerosis

Alaupovic, 1984, The physicochemical and immunological heterogeneity of human plasma high-density lipoproteins, 1

Arntzenius, 1986, Diet, lipoproteins and the progression of coronary atherosclerosis, Drugs, 31, 61, 10.2165/00003495-198600311-00011

Assmann, 1986, New aspects in the prediction of coronary artery disease: The Prospective Cardiovascular Munster Study, 19

Avogaro, 1984, Familial hyperalphalipoproteinaemia, 289

Barter, 1984, HDL metabolism in relation to plasma cholesteryl ester transport, 167

Berge, 1982, High-density lipoprotein cholesterol and prognosis after myocardial infarction, Circulation, 66, 1176, 10.1161/01.CIR.66.6.1176

Blum, 1985, Relationship of the parameters of body cholesterol metabolism with plasma level of HDL cholesterol and the major HDL apoproteins, Journal of Lipid Research, 26, 1079, 10.1016/S0022-2275(20)34281-4

Bondjers, 1976, Cholesterol content in arterial tissue in relation to serum lipoproteins in man, Artery, 2, 200

Bondjers, 1980, Alphalipoprotein cholesterol and arterial cholesterol in human uterine arteries, Artery, 8, 388

Burstein, 1973, Lipoprotein-polyanion-metal interactions, Advances in Lipid Research, 11, 67, 10.1016/B978-0-12-024911-4.50009-X

Carlson, 1982, Fish-eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia, European Journal of Clinical Investigation, 12, 41, 10.1111/j.1365-2362.1982.tb00938.x

Desai, 1986, Aggregation of isolated platelets is inhibited by the plasma high-density lipoprotein subclass, HDL1, Biochemical Society Transactions, 14, 723, 10.1042/bst0140723

Duffield, 1983, Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomized controlled trial, Lancet, ii, 639, 10.1016/S0140-6736(83)92527-8

Eisenberg, 1984, High density lipoprotein metabolism, Journal of Lipid Research, 25, 1017, 10.1016/S0022-2275(20)37713-0

Fears, 1984, Hyperalphalipoproteinaemic activity of BRL26314—II. Inhibition of atherosclerosis in rabbits, Biochemical Pharmacology, 33, 219, 10.1016/0006-2952(84)90479-9

Flow, 1984, Relationship of high density lipoprotein cholesterol to cholesterol metabolism in the baboon (Papio sp.), Journal of Lipid Research, 25, 469, 10.1016/S0022-2275(20)37798-1

Franceschini, 1980, A-IMilano apoprotein. Decreased high density lipoprotein cholesterol level with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family, Journal of Clinical Investigation, 66, 892, 10.1172/JCI109956

Goldbourt, 1986, High density lipoprotein cholesterol: prognosis after myocardial infarction. The Israeli Ischaemic Heart Disease Study, International Journal of Epidemiology, 15, 51, 10.1093/ije/15.1.51

Gundersen, 1985, Timolol maleate and HDL cholesterol after myocardial infarction, European Heart Journal, 6, 840, 10.1093/oxfordjournals.eurheartj.a061770

Havel, 1986, Functional activities of hepatic lipoprotein receptors, 48, 119

Holme, 1981, Risk factors and raised atherosclerotic lesions in coronary and cerebral vessels. Statistical analysis from the Oslo Study, Arteriosclerosis, 1, 250, 10.1161/01.ATV.1.4.250

Karathanasis, 1983, A DNA insertion in the apolipoprotein AI gene of patients with premature atherosclerosis, Nature, 305, 823, 10.1038/305823a0

Katan, 1984, Diet and HDL, 103

Kostner, 1979, Determination of high-density lipoproteins: screening methods compared, Clinical Chemistry, 25, 939, 10.1093/clinchem/25.6.939

Levy, 1984, The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study, Circulation, 69, 325, 10.1161/01.CIR.69.2.325

LRC Program, 1984, The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol-lowering, Journal of the American Medical Association, 251, 365, 10.1001/jama.1984.03340270043026

Luis, 1986, Genetic control of plasma lipid transport: mouse model, vol. 128, 877

Maciejko, 1983, Apolipoprotein AI as a marker of angiographically assessed coronary artery disease, New England Journal of Medicine, 309, 385, 10.1056/NEJM198308183090701

Magill, 1982, Relationships between the metabolism of high-density and very-low density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity, European Journal of Clinical Investigation, 12, 113, 10.1111/j.1365-2362.1982.tb00947.x

Miller, 1983, High density lipoprotein, atherosclerosis and ischaemic heart disease, 153

Miller, 1986, High density lipoprotein as a predictor of clinical coronary heart disease, 61

Miller, 1987, On the associations of body cholesterol pool size with age, HDL cholesterol and plasma total cholesterol concentration in humans, Atherosclerosis, 10.1016/0021-9150(87)90276-0

Miller, 1987, Metabolic determinants of plasma high-density lipoprotein concentration in humans

Miller, 1987, Associations of HDL subclasses and apolipoproteins with ischaemic heart disease and coronary atherosclerosis, American Heart Journal, 113, 589, 10.1016/0002-8703(87)90638-7

Miller, 1987, Can we retard atherogenesis by modifying high-density lipoprotein metabolism?

Miller, 1987, Effects of adrenoreceptor-blocking drugs on plasma lipoprotein concentrations in man: metabolic basis and possible clinical implications, American Journal of Cardiology, 10.1016/0002-9149(87)90537-6

Miller, 1976, Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man, Atherosclerosis, 23, 535, 10.1016/0021-9150(76)90013-7

Mills, 1984

1986, Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial, Preventive Medicine, 15, 254, 10.1016/0091-7435(86)90045-9

Muuronen, 1985, Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study, British Medical Journal, 291, 1481, 10.1136/bmj.291.6507.1481

Nestel, 1980, Cholesterol kinetics and faccal steroid excretion in subjects with primary hyperalphalipoproteinaemia, Atherosclerosis, 36, 127, 10.1016/0021-9150(80)90206-3

Nikkila, 1984, Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia, British Medical Journal, 289, 220, 10.1136/bmj.289.6439.220

Norum, 1982, Familial deficiency of apolipoproteins AI and CIII and precocious coronary artery disease, New England Journal of Medicine, 306, 1513, 10.1056/NEJM198206243062503

Ordovas, 1986, Apolipoprotein AI gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia, New England Journal of Medicine, 314, 671, 10.1056/NEJM198603133141102

Pocock, 1986, High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men, British Medical Journal, 292, 515, 10.1136/bmj.292.6519.515

Pownall, 1978, Composition and structure of high density lipoprotein, 5

Price, 1985, Are plasma lipoprotein cholesteryl esters utilized for biliary cholesterol and bile acid production in man?, Life Sciences, 36, 2217, 10.1016/0024-3205(85)90332-7

Reichl, 1986, The anatomy and physiology of reverse cholesterol transport, Clinical Science, 70, 221, 10.1042/cs0700221

Schaefer, 1985, Familial apolipoprotein AI and CIII deficiency, variant II, Journal of Lipid Research, 26, 1089, 10.1016/S0022-2275(20)34282-6

Schmitz, 1985, Tangier disease: a disorder of intracellular membrane traffic, 82, 6305

Tall, 1986, Plasma lipid transfer proteins, Journal of Lipid Research, 27, 361, 10.1016/S0022-2275(20)38819-2

Van Sickle, 1986, High density lipoprotein-induced cardiac prostacyclin synthesis in vitro: relationship to cardiac arachidonate mobilization, Journal of Lipid Research, 27, 517, 10.1016/S0022-2275(20)35189-0

Warnick, 1985, Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol, Clinical Chemistry, 31, 217, 10.1093/clinchem/31.2.217